Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
about
Tuberculin skin test result and risk of death among persons with active TBHIV and Tuberculosis: a Deadly Human Syndemic2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controlsHuman immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costs.Tuberculosis and HIV infection: epidemiology, immunology, and treatment.Tuberculosis and illicit drug use: review and update.Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug usersGenome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania.Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.Tuberculosis in the homeless. A prospective study.Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses
P2860
Q28535009-7493E440-6C6D-46AC-AA96-D923AA64F8DAQ30052157-4975EA32-AE73-451D-9D2C-B9B00BD8B8A1Q33634631-D05B64E2-AE02-4248-B79B-DC234A04ED74Q33746007-A2E8ACF6-284B-45CF-BCE9-BACB3DC7BF5FQ34394728-3841CEC4-01FD-47B2-97B0-73A5080595AFQ34601143-2D28DC2F-2202-46AB-AEA6-D04960A40576Q34999732-318551F3-5296-41DF-B48F-518040E01AA9Q35097330-92AB4D0A-3542-4CAA-A16B-2F6066460830Q35864772-3F062B1C-B7EB-4134-A59C-98BB02076050Q36274729-E507828F-120F-4B40-9E49-8865E18AC1C8Q39511808-A04D44C9-02E6-4351-BFFE-183223808798Q41753577-222C8370-615F-4EF8-A5FF-42ABFB13D598Q52281056-E29162E9-D379-4798-97EA-6EADE656BB31Q57209233-7D32B4AC-C08A-404A-884A-32126BC3A462
P2860
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@en
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@nl
type
label
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@en
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@nl
prefLabel
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@en
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@nl
P2093
P2860
P1476
Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
@en
P2093
P2860
P356
10.1164/AJRCCM.157.1.9701111
P407
P577
1998-01-01T00:00:00Z